/C O R R E C T I O N — Global Health Exhibition/
In the news release, Global Health Exhibition Opens in Riyadh With SAR 50 Billion Announced in Healthcare Investments on First Day, issued 21-Oct-2024 by Global Health Exhibition over PR Newswire, we are advised by the company that the city or origin should read “RIYADH, Saudi Arabia” rather than “MALHAM, England and RIYADH, Saudi Arabia” as originally issued inadvertently. The complete, corrected release follows:
-
Global Health Exhibition kicks off under the theme “Invest in Health” at the Riyadh International Convention and Exhibition Center in Malham, north of Riyadh
-
Sponsors include Saudi Commission for Health Specialities as the Strategic Partner; Health Holding, NUPCO, Mobily and Lean as Foundation Partners; STC as Digital Enabler and Dallah Health and Tawuniya as Diamond Sponsors
RIYADH, Saudi Arabia, Oct. 21, 2024 /PRNewswire/ — The Global Health Exhibition, under the patronage of the Saudi Ministry of Health and organized by Tahaluf, opened with a total of SAR 50 billion in investments – announced on the first day.
During the opening ceremony, the Minister of Health, His Excellency Fahd bin Abdurrahman Al-Jalajel, highlighted the impact of health transformation in the sector, stating: “We aim to position Saudi Arabia as a hub for addressing current and future global challenges, following a unified government approach under Vision 2030. This is based on the principle of ‘health in all policies’ by developing regulations that encourage investment in innovation, building a healthcare system that unleashes the power of digital solutions and artificial intelligence, and developing local healthcare talent while attracting the best minds from around the world. These efforts are driving us forward in our health transformation with concrete and measurable steps.”
He added, “Today, we are proud of the World Health Organization’s recognition of Saudi Arabia’s elimination of trans fats from food products, placing the Kingdom at the forefront of countries receiving this distinction. Additionally, the WHO has announced that Saudi Arabia, represented by the Saudi Food and Drug Authority, is the first country in the region to achieve the highest ‘maturity level 4’ in the regulation of medicines and vaccines.”
As part of the SAR 50 billion investments announced, a SAR 4 billion pharmaceutical manufacturing deal between NUPCO, Novo Nordisk, and Sanofi was highlighted, as well as a SAR 5 billion expansion in Faqih Medical Group, and the construction of five primary care centers and two hospitals by Al Mousa Healthcare at a value of SAR 3 billion. Additionally, over SAR 10bn of investment was announced by Dr Sulaiman Al Habib Group in “developing and operating several prominent healthcare projects”.
link
